Laurus Labs
Generic drug makerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in IndiaLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
- Group recordsLabelled by a language model (which subsidiaries belong to the group) from the firm's FDA names. It is not an FDA field.: 33, 2 entities
- Drug applications: 32
- Complete response letters: 1
Records by Year
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date, Laurus Labs and its 1 subsidiaries
Latest Records
Newest first across sources; each opens the record| Date | Record | Source |
|---|---|---|
| Mar 10, 2025 | Complete response letter, NDA 217719Unapproved | Complete response letters |
Subsidiaries and Divisions
1 firms in the Laurus Labs group, most records first- Laurus Generics3 records
Canada and Imports
Across the Laurus Labs group, matched by company name- FDA import refusals since 2024
- 3 shipment lines, through Oct 23, 2026
Names and Identifiers
- Appears as
- Website
- lauruslabs.com
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built